EIF4E and cancer: Nonetheless, a number of recent studies, including our own, demonstrate that deregulation of cap-dependent translation by an incomplete inhibition of 4E-BP1 phosphorylation, reduction of 4E-BP1 expression, or upregulation of eIF4E expression renders cancer cell resistance to mTORkis11–16.